Aphea.Bio

Aphea.Bio is a Belgium-based biotechnology startup founded in 2017, with a mission to revolutionize agriculture through the use of biological solutions. The company's innovative approach focuses on harnessing the diversity of microorganisms to develop biocontrol and biostimulant products that serve as effective alternatives to chemical pesticides and synthetic fertilizers. Their APEXbioTM R&D platform, combined with a dedicated team of researchers and industry experts, emphasizes the integration of cutting-edge science with traditional knowledge, fostering a spirit of innovation and result-driven science. In July 2023, Aphea.Bio secured a significant €70.00M Series C investment from a diverse group of investors, including Astanor Ventures, Bill & Melinda Gates Foundation, BNP Paribas Fortis, ECBF, SFPIM, Innovation Industries, Agri Investment Fund, and Korys. This investment highlights the industry's confidence in the company's potential and its commitment to transforming agriculture through the power of nature's biodiversity. Aphea.Bio's emphasis on sustainability and collaboration is evident through its B Corp certification and global partnerships with academic institutions, industry partners, and farmers. The company envisions a future where agriculture coexists harmoniously with nature, promoting biodiversity and leaving a healthier planet for future generations. With a focus on reducing agriculture's ecological footprint while enhancing productivity and sustainability, Aphea.Bio is poised to make a significant impact on the agricultural industry.